Novartis AG
NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
$160.79−0.31 (-0.19%)
Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –
Novartis Canada & Latin America by Year
Novartis Canada & Latin America: 403 in FY2025, up 19.9% from a year earlier.
Latest, FY2025
403
Period ended Dec 31, 2025
Change on a year earlier
+19.9%
336 in FY2024
History
3 years
Since FY2023
Sources
1
Novartis Form 20-F (0001114448-26-000004)
Where the FY2025 figure comes from
“|| Canada and Latin America | 1 970 | 475 | 403 | 1 085 | 3 933”
Source: Novartis Form 20-F (0001114448-26-000004) ↗
Reported in Form 20-F.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Canada & Latin America | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 403 | +19.9% | Novartis Form 20-F (0001114448-26-000004) ↗ |
| FY2024 | Dec 31, 2024 | 336 | +2.8% | Novartis Form 20-F (0001114448-26-000004) ↗ |
| FY2023 | Dec 31, 2023 | 327 | – | Novartis Form 20-F (0001114448-26-000004) ↗ |
Cite this data
StockData. (2026). Novartis Canada & Latin America, annual FY2023–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/wf-fte-prod-canlatam
See every metric in the Novartis KPI table. Data updated Nov 2, 2026.